AzTrials
AzTrials

StrokeNCT03229733

Design and Evaluation the Effects of Kinect-based Computer Games for U/E Training in Chronic Stroke Patients

A study testing Kinect and Traditional occupational therapy in people with Stroke, run by Chang Gung Memorial Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aims of this study are to (i) develop exergames by using Kinect system for training UE function in patient with stroke; and (ii) to test the game's feasibility and effects in a group of patient with chronic stroke. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
Kinect and Traditional occupational therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
No sites listed yet
Study dates
Nov 2015to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First ever ischemic or hemorrhagic stroke or former stroke without any significant residual motor impairment
  • 3 months post stroke
  • Impaired arm motor function at Brunnstrom stage 3-5
  • Age 18 years or older

Who cannot join

  • severe cognitive impairment defined as < 20 on Mini Mental State Examination
  • visual disorders or neglect limiting the ability to comply with treatment regimen
  • orthopedic problem or other neurological diagnosis that makes the UE dysfunction.

About this study

Official title: Design and Evaluation the Feasibility, Effects of Kinect-based Computer Games for Rehabilitation Training of Upper Extremity Function in Patients With Chronic Stroke

The aims of this study are to (i) develop exergames by using Kinect system for training UE function in patient with stroke; and (ii) to test the game's feasibility and effects in a group of patient with chronic stroke.

Read the detailed description

Exercise based computer games can facilitate high volume complex task practice, enhance feedback of movement and increase motivation of participants. Those effects are difficult to achieve with standard rehabilitation therapy. The Kinect system is a camera-based controller which a player can use to directly control a game through body movement without the need for handheld controllers. Using Kinect to capture movement is a feasible way to help patients who have difficulties to hold controllers to play exergames. Scratch 2.0 is a programming language for kids from the MIT Media Laboratory. It is easy to use for game designing. Kinect2Scratch allows data from the Microsoft Kinect controller to be sent to Scratch, This means that game programs can be designed with motion control. The aims of this study were to i) develop exergames by using Scratch and Kinect system for training upper extremity function in patient with stroke; and ii) to test the game's feasibility and effects in a group of patient with chronic stroke.

This program will be done within two years. During the first year, investigators will design several exergames which are suitable for training upper extremity function in patient with stroke. Investigators will have several experts meetings, involved by physiatrists, occupational therapists and engineers to design the game. When a prototype game is created, investigators will invite two to four patients with stroke to pilot test the game. The game design will be completed till patients and therapists satisfy the design.

During the 2nd year, investigators will test the feasibility and effects of the exergames by doing a pilot randomized control trial. Investigators will recruit 60 patients with chronic stroke who are admitted to a rehabilitation ward for outpatient rehabilitation, and will randomize participants to experiment or control group. All participants will receive PT and OT training as routine. The additional intervention either exergames or conventional OT will be delivered for 8 weeks with 3 training sessions/week of up to 30 minutes.

Conditions
Stroke
Being tested
Kinect, Traditional occupational therapy
Keywords
Stroke, Kinect, Rehabilitation, Upper limbs
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KinectDevice

    Receive Kinect games training for 30 minutes. There are 3 sections for 1 week; the intervention period will be 8 weeks

  • Traditional occupational therapyBehavioural

    Patients will receive individually tailored conventional training consisting of the similar movement and dose by using the traditional equipment, such as climbing bar.

Study groups in NCT03229733
Study groupRoleWhat they receive
Experimental groupExperimentalPatients randomized to the experimental group participate in exergames training with Kinect. The supervised OT chooses different games according to the patient's needs and abilities. During therapy patients are at sitting position. The game program will be adjusted when patients got improvement. After 30 minutes of exergames training, participants will receive a 30-minutes of traditional occupational therapy.
Receives: Device: Kinect; Behavioral: Traditional occupational therapy
Control groupActive comparatorPatients in the control group will receive individually tailored traditional occupational therapy consisting of the similar movement and dose as the experimental group doing by using the traditional equipment, such as climbing bar.
Receives: Behavioral: Traditional occupational therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor function assessed on Fugl-Meyer Assessment (FMA)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

Secondary outcomes (7)
  1. The amount of movement assessed on Actigraph Assessment

    The outcome will be measured at 2 time points: 0 week, and 8 weeks after recruitment.

    Measured: Change from baseline at 2 months

  2. The upper extremity motor ability assessed on Wolf Motor Function Test (WMFT)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

  3. The quality of movement and amount of use assessed on Motor Activity Log (MAL)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

  4. The instrumental activities of daily living assessed on Nottingham Extended Activities of Daily Living Scale (NEADL)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

  5. The relevant for upper-extremity function self-report questionnaire on Stroke Impact Scale (SIS)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

  6. Standing balance assessed on The Functional reach test (FR)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

  7. Muscle power assessed on Medical Research Council Scale (MRC)

    The outcome will be measured at 3 time points: 0 week, 8 weeks, and 5 months after recruitment.

    Measured: Change from baseline at 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2017
  2. Study startNov 2015
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03229733
Sponsor's protocol ID
CMRPG8E0931
Status last verified
Feb 2017
First submitted
23 Jul 2017
Last updated
18 Jul 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Noorkoiv M, Rodgers H, Price CI. Accelerometer measurement of upper extremity movement after stroke: a systematic review of clinical studies. J Neuroeng Rehabil. 2014 Oct 9;11:144. doi: 10.1186/1743-0003-11-144.

    PubMed 25297823
  • Adams RJ, Lichter MD, Krepkovich ET, Ellington A, White M, Diamond PT. Assessing upper extremity motor function in practice of virtual activities of daily living. IEEE Trans Neural Syst Rehabil Eng. 2015 Mar;23(2):287-96. doi: 10.1109/TNSRE.2014.2360149. Epub 2014 Sep 24.

    PubMed 25265612
  • Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke. 2001 Jul;32(7):1635-9. doi: 10.1161/01.str.32.7.1635.

    PubMed 11441212

Questions about this trial

What is this clinical trial studying?

A study testing Kinect and Traditional occupational therapy in people with Stroke, run by Chang Gung Memorial Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor function assessed on Fugl-Meyer Assessment (FMA) (time frame: Change from baseline at 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03229733, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in